Factors influencing surgical treatment of bisphosphonate‐related osteonecrosis of the jaws
Head & Neck2011Vol. 34(2), pp. 194–200
Citations Over TimeTop 10% of 2011 papers
Arno Wutzl, Sebastian Pohl, Irene Sulzbacher, Rudolf Seemann, Günter Lauer, Rolf Ewers, Johannes Drach, Clemens Klug
Abstract
Surgery is more successful in patients with osteoporosis or multiple myeloma than in those with solid tumors. Discontinuation of bisphosphonate therapy favored the surgical outcome.
Related Papers
- → Updates on bisphosphonates and potential pathobiology of bisphosphonate‐induced jaw osteonecrosis(2007)133 cited
- → Management of bisphosphonate‐related osteonecrosis of the jaw: a literature review(2015)41 cited
- → [Bisphosphonate-related osteonecrosis of the jaw caused by implant: a case report].(2020)2 cited
- → Risk Factors for Bisphosphonate-Related Osteonecrosis of the Jaws(2011)2 cited
- Prevention of Osteonecrosis of the Jaw (ONJ) in Patients on Bisphosphonate Therapies - NSW Department of Health(2010)